16,16-dimethylprostaglandin A1

structure given in first source; RN given for (13E,15R)-isomer; RN for cpd without isomeric designation not available 12/92; effective against HIV-1 and herpes simplex virus

Also Known As:

16,16-diMe-PGA1; dmPGA1

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Synthetic Prostaglandins: 823
        Synthetic Prostaglandins A: 1
        16,16-dimethylprostaglandin A1: 1
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Synthetic Prostaglandins: 823
    - Synthetic Prostaglandins A: 1
      - 16,16-dimethylprostaglandin A1: 1
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Synthetic Prostaglandins: 823
        Synthetic Prostaglandins A: 1
        16,16-dimethylprostaglandin A1: 1

Related Diseases

1.	HIV Infections (HIV Infection) 10/01/1992 - "dmPGA1 significantly inhibited viral replication in both HSV and HIV infection systems at concentrations of dmPGA1 that did not adversely alter cellular DNA synthesis. "

Related Drugs and Biologics

1.	DNA (Deoxyribonucleic Acid)